TP53 and hepatocellular carcinoma: According to these findings, patients who overexpress PSRC1 showed an enhanced loss-of-function mutation rate in TP53 gene, possibly explaining the absence of correlation between PSRC1 and TP53 expressions in HCC samples, as an escape from the TP53-mediated mechanisms of tumor suppression.